TD Asset Management
RAPT

TD Asset Management’s RAPT Therapeutics RAPT Stock Holding History

TD Asset Management’s Portfolio RAPT Stock Details RAPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1,533
Closed -$24K – 1376
2024
Q3 		$24K Hold
1,533
– – ﹤0.01% 1378
2024
Q2 		$37.4K Hold
1,533
– – ﹤0.01% 1354
2024
Q1 		$110K Sell
1,533
-13,169
-90% -$1.83M ﹤0.01% 1371
2023
Q4 		$2.92M Sell
14,702
-4,500
-23% -$557K ﹤0.01% 888
2023
Q3 		$2.55M Buy
19,202
+7,729
+67% +$1.26M ﹤0.01% 890
2023
Q2 		$1.72M Sell
11,473
-213
-2% -$33.2K ﹤0.01% 1001
2023
Q1 		$1.72M Hold
11,686
– – ﹤0.01% 1018
2022
Q4 		$1.85M Sell
11,686
-356
-3% -$57K ﹤0.01% 1012
2022
Q3 		$2.3M Hold
12,042
– – ﹤0.01% 962
2022
Q2 		$1.76M Sell
12,042
-214
-2% -$28.5K ﹤0.01% 1046
2022
Q1 		$2.16M Sell
12,256
-1,312
-10% -$248K ﹤0.01% 1068
2021
Q4 		$3.99M Buy
13,568
+3,113
+30% +$832K ﹤0.01% 928
2021
Q3 		$2.6M Buy
10,455
+725
+7% +$192K ﹤0.01% 1008
2021
Q2 		$2.39M Buy
9,730
+1,640
+20% +$306K ﹤0.01% 1039
2021
Q1 		$1.44M Buy
8,090
+445
+6% +$73.4K ﹤0.01% 1183
2020
Q4 		$1.21M Buy
7,645
+399
+6% +$86.8K ﹤0.01% 1139
2020
Q3 		$1.87M Buy
7,246
+3,900
+117% +$866K ﹤0.01% 925
2020
Q2 		$777K Buy
3,346
+1,384
+71% +$214K ﹤0.01% 1121
2020
Q1 		$334K Buy
1,962
+351
+22% +$79.9K ﹤0.01% 1253
2019
Q4 		$356K Buy
+1,611
New +$297K ﹤0.01% 1294

Other funds holding RAPT

MVM
Medicxi Ventures Management St. Helier, Jersey $982M AUM 210.17% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
FCMV
Foresite Capital Management VI Larkspur, California $460M AUM 261.77% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

TD Asset Management's RAPT Position: Q4 2024 in Review

TD Asset Management sold out of RAPT Therapeutics (RAPT) in Q4 2024, closing a stake of 1,533 shares — an estimated $24K sold.

TD Asset Management first reported a position in RAPT in Q4 2019 and held it in 20 quarters. The position peaked at $3.99M in Q4 2021. 91 funds tracked by Wall St. Rank hold RAPT as of Q4 2024.

  • TD Asset Management reported no remaining RAPT Therapeutics position as of Q4 2024 after selling out during the quarter.
  • TD Asset Management sold 1,533 RAPT Therapeutics shares in Q4 2024, an estimated $24K.
  • TD Asset Management first reported a position in RAPT Therapeutics in Q4 2019 and held it in 20 quarters.
  • TD Asset Management's RAPT Therapeutics position peaked at $3.99M in Q4 2021.
  • 91 funds tracked by Wall St. Rank held RAPT Therapeutics as of Q4 2024.

Based on TD Asset Management's 13F filing for Q4 2024, filed 11 Feb 2025.